|
Multisystem inflammatory syndrome in children (or MIS-C) is a serious complication of Covid-19 infection, usually showing up about a month after infection.
CDC worked with several hospitals around the U.S. to discern whether vaccination in adolescents would lessen the likelihood of this outcome. A vaccine hadn’t yet been approved, as it now is, for kids between 5 and 11)
The bottom line is that vaccination with BNT16b2 (colloquially known as Pfizer-BioNTech) proved over 90% effective in preventing MIS-C.
Listen in as we discuss the work with CDC’s Laura Zambrano. The interview runs about 15 minutes.
The article in MMWR (free)
[A full transcript will folllow in a day or so, and I’ll attach it here.]
The post Podcast 280: MIS-C after Covid-19 in adolescents — can vaccination prevent it? first appeared on Clinical Conversations. |